JFNSX
Janus Henderson Global Life Sciences Fund - S Shares
$88.09
Janus Henderson Global Life Sciences Fund - S Shares (JFNSX)
The Janus Henderson Global Life Sciences Fund Class S endeavors to achieve substantial capital appreciation over the long term. Its primary strategy involves allocating a minimum of 80% of its net assets (including any borrowed capital utilized for investment purposes) to businesses that its portfolio managers identify as having a strong life science orientation. Furthermore, as a foundational commitment to this focus, the fund has a fundamental policy to typically allocate at least 25% of its total assets to securities issued by companies formally classified within the "life sciences" sector.
JFNSX Mutual Fund Chart & Stats
$88.09
At close: 4:00 PM EST- Previous Close
- $88.09
- Sub-Category
- Global,International
- Total Liabilities
- $11.19M
- Last Dividend Ex-Date
- Dec 05, 2025
- Expense Ratio
- 1.19%
- Holding Count
- 84
- Brand
- Janus Investment Fund
- Dividend Yield
- (3.98%)
- Category
- Equity
- Total Assets
- 5.82B
- Shares Outstanding
- N/A
- 52-Week Range
- $71.20 - $90.17
JFNSX Mutual Fund News
JFNSX Mutual Fund Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| LLYEli Lilly And Company | 9.41% |
| JNJJohnson & Johnson | 7.09% |
| ABBVAbbvie | 4.67% |
| UNHUnitedhealth Group Inc. | 4.54% |
| AZNAstraZeneca plc | 3.93% |
| RVMDRevolution Medicines, Inc. | 3.02% |
| ARGXArgenx | 2.63% |
| NVSNovartis AG | 2.56% |
| TMOThermo Fisher Scientific | 2.33% |
| PRAXPraxis Precision Medicines, Inc. | 2.19% |
| Total | 42.37% |
Recently Viewed
No data currently available






